Cullinan Therapeutics Inc
CGEM10.370USD
+0.110+1.07%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
612.62MMarket Cap
LossP/E TTM
Cullinan Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-3.11
15.55%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -3.113, with a year-on-year change of 15.55%.
What is the net income of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its net income was -167.38M, with a year-on-year change of -9.28%.
What is the net margin of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -32.06%, with a year-on-year change of -3.50%.
What is the Return on Assets (ROA) of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -30.30%, with a year-on-year change of -2.11%.
What is the operating profit of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its operating profit was -196.92M, with a year-on-year change of -3.29%.
What are the current assets of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its current assets were 414.67M, with a year-on-year change of -13.65%.
What are the total assets of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its total assets of Cullinan Therapeutics Inc were 621.82M, with a year-on-year change of 28.43%.
What are the total liabilities of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its total liabilities of Cullinan Therapeutics Inc were 31.50M, with a year-on-year change of 3.99%.
What is the total equity of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its total equity of Cullinan Therapeutics Inc was 590.33M, with a year-on-year change of 30.06%.
What is the net operating income of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its net operating income of Cullinan Therapeutics Inc was -167.57M, with a year-on-year change of -8.04%.
What is the net investment of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its net investment of Cullinan Therapeutics Inc was -136.31M, with a year-on-year change of -480.70%.
What is the net financing of Cullinan Therapeutics Inc?
According to Cullinan Therapeutics Inc's FY2024 earnings report, its net financing of Cullinan Therapeutics Inc was 266.19M, with a year-on-year change of 553.21%.
